Applied Therapeutics

$16.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.30 (-1.82%) As of 7:23 PM UTC today

Why Robinhood?

You can buy or sell APLT and other stocks, options, and ETFs commission-free!

About APLT

Applied Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of unmet medical need.

CEO
Shoshana Shendelman
Employees
24
Headquarters
New York, New York
Founded
2016
Market Cap
429.50M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
96.05K
High Today
$16.81
Low Today
$16.21
Open Price
$16.68
Volume
50.66K
52 Week High
$51.99
52 Week Low
$13.58

APLT Earnings

-$1.33
-$0.89
-$0.44
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 11, Pre-Market

You May Also Like

ATKR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure